
Robyn Scherber
Specialist · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Credentials: · · · ·
History
Research
Journal of Clinical Oncology · 2012 · First of 44 authors · 375 citations
Blood · 2011 · First of 16 authors · 294 citations
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide
Blood · 2017 · 133 citations

41 papers

20 papers · 2 as a fellow
- SV
6 papers

5 papers

4 papers
- NM
4 papers

3 papers

3 papers
Clinical trials
- 2016–2022
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Study director · Completed
Incyte Corporation
- 2014–2019
Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Study director · Completed
Incyte Corporation





